Anshuman Sakle

Anshuman is a Partner at Khaitan & Co in the Competition/Antitrust practice, bringing over fifteen years of expertise in Indian competition law. His work spans complex merger control cases, abuse of dominance, cartel investigations, and compliance, with notable cases including Sun Pharma’s acquisition of Ranbaxy and Hospira’s acquisition of Orchid Chemicals. He has advised on major transactions for clients like Ipca Labs, Mubadala, and the Adani Group, and has defended clients such as Viterra India against cartel charges. Anshuman is an active writer, contributing to various national and international publications, and serves on the editorial boards of notable legal journals. He is recognized as a Global Elite Thought Leader by Who's Who Legal, a Distinguished Practitioner by Asialaw, and ranked in the Top 40 under 40 – Asia Pacific by Benchmark Litigation in 2024, Anshuman has consistently been ranked by Chambers & Partners and is also noted as a Litigation Star.